Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Howraman Meteran

Showing results (61-70 of 70) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 70 results.
Journal of Crohn'S & Colitis|June 30, 2026
Risk and outcome of interstitial lung disease in inflammatory bowel disease: evidence from a Danish nationwide population-based cohort studyJonas A Baekdal, Erik Sören Halvard Hansen, Howraman Meteran, et al.
Journal of Asthma and Allergy|June 12, 2025
Prevalence, Change and Burden of Systemic Corticosteroid Use in Type 2 Inflammation Associated Diseases Over 25 Years - A Nationwide Danish StudyKjell Erik Julius Håkansson, Inge Raadal Skov, Steven Arild Wuyts Andersen, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|May 21, 2026
National and Individual-Level Economic Burden of Local Corticosteroid Use and Concomitant Use of Multiple Local Corticosteroid Formulations-A Nationwide Cohort StudyKjell Erik Julius Håkansson, Jonas Bækdal, Inge Raadal Skov, et al.
The Lancet Regional Health. Europe|July 19, 2023
Efficacy and safety of oral roflumilast for moderate-to-severe psoriasis-a randomized controlled trial (PSORRO)Mette Gyldenløve, Howraman Meteran, Jennifer A Sørensen, et al.
Thorax|August 27, 2021
Use of inhaled corticosteroids and risk of acquiring <i>Pseudomonas aeruginosa</i> in patients with chronic obstructive pulmonary diseaseJosefin Eklöf, Truls Sylvan Ingebrigtsen, Rikke Sørensen, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|June 4, 2021
Hydroxychloroquine as a primary prophylactic agent against SARS-CoV-2 infection: A cohort studyPeter Kamstrup, Pradeesh Sivapalan, Josefin Eklöf, et al.
BMJ Open Respiratory Research|August 23, 2023
Phenotyping asthma with airflow obstruction in middle-aged and older adults: a CADSET clinical research collaborationXander Bertels, Ahmed Edris, Judith Garcia-Aymerich, et al.
Biomedicines|August 27, 2021
Systemic Corticosteroids and the Risk of Venous Thromboembolism in Patients with Severe COPD: A Nationwide Study of 30,473 OutpatientsEma Rastoder, Pradeesh Sivapalan, Josefin Eklöf, et al.
The European Respiratory Journal|June 4, 2021
Azithromycin and hydroxychloroquine in hospitalised patients with confirmed COVID-19: a randomised double-blinded placebo-controlled trialPradeesh Sivapalan, Charlotte Suppli Ulrik, Therese Sophie Lapperre, et al.
Trials|June 12, 2020
Proactive Prophylaxis With Azithromycin and HydroxyChloroquine in Hospitalised Patients With COVID-19 (ProPAC-COVID): A structured summary of a study protocol for a randomised controlled trialPradeesh Sivapalan, Charlotte Suppli Ulrik, Rasmus Dahlin Bojesen, et al.
Pageof 7

Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
Journal of Crohn'S & Colitis|June 30, 2026
Risk and outcome of interstitial lung disease in inflammatory bowel disease: evidence from a Danish nationwide population-based cohort studyJonas A Baekdal, Erik Sören Halvard Hansen, Howraman Meteran, et al.
Journal of Asthma and Allergy|June 12, 2025
Prevalence, Change and Burden of Systemic Corticosteroid Use in Type 2 Inflammation Associated Diseases Over 25 Years - A Nationwide Danish StudyKjell Erik Julius Håkansson, Inge Raadal Skov, Steven Arild Wuyts Andersen, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|May 21, 2026
National and Individual-Level Economic Burden of Local Corticosteroid Use and Concomitant Use of Multiple Local Corticosteroid Formulations-A Nationwide Cohort StudyKjell Erik Julius Håkansson, Jonas Bækdal, Inge Raadal Skov, et al.
The Lancet Regional Health. Europe|July 19, 2023
Efficacy and safety of oral roflumilast for moderate-to-severe psoriasis-a randomized controlled trial (PSORRO)Mette Gyldenløve, Howraman Meteran, Jennifer A Sørensen, et al.
Thorax|August 27, 2021
Use of inhaled corticosteroids and risk of acquiring <i>Pseudomonas aeruginosa</i> in patients with chronic obstructive pulmonary diseaseJosefin Eklöf, Truls Sylvan Ingebrigtsen, Rikke Sørensen, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|June 4, 2021
Hydroxychloroquine as a primary prophylactic agent against SARS-CoV-2 infection: A cohort studyPeter Kamstrup, Pradeesh Sivapalan, Josefin Eklöf, et al.
BMJ Open Respiratory Research|August 23, 2023
Phenotyping asthma with airflow obstruction in middle-aged and older adults: a CADSET clinical research collaborationXander Bertels, Ahmed Edris, Judith Garcia-Aymerich, et al.
Biomedicines|August 27, 2021
Systemic Corticosteroids and the Risk of Venous Thromboembolism in Patients with Severe COPD: A Nationwide Study of 30,473 OutpatientsEma Rastoder, Pradeesh Sivapalan, Josefin Eklöf, et al.
The European Respiratory Journal|June 4, 2021
Azithromycin and hydroxychloroquine in hospitalised patients with confirmed COVID-19: a randomised double-blinded placebo-controlled trialPradeesh Sivapalan, Charlotte Suppli Ulrik, Therese Sophie Lapperre, et al.
Trials|June 12, 2020
Proactive Prophylaxis With Azithromycin and HydroxyChloroquine in Hospitalised Patients With COVID-19 (ProPAC-COVID): A structured summary of a study protocol for a randomised controlled trialPradeesh Sivapalan, Charlotte Suppli Ulrik, Rasmus Dahlin Bojesen, et al.
Pageof 7